CL3-78989-005. EYEGUARD-A study

• Research type

  Research Study

• Full title

  A RandomizEd, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of Gevokizumab in the TReatment of Active Non-infectious IntermeDiate, Posterior, or Pan- Uveitis

• IRAS ID

  112718

• Contact name

  Carlos Pavesio

• Contact email

  carlos.pavesio@moorfields.nhs.uk

• Sponsor organisation

  XOMA (US) LLC

• Eudract number

  2012-001610-42

• ISRCTN Number

  ISRCTN

• Clinicaltrials.gov Identifier

  NCT

• REC name

  London - Central Research Ethics Committee

• REC reference

  13/LO/0716

• Date of REC Opinion

  19 Aug 2013

• REC opinion

  Further Information Favourable Opinion